Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Kilkus

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta|November 10, 2015
The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activityJingdong Qin, John Kilkus, Glyn Dawson
Neurochemical Research|October 11, 2002
CrmA protects against apoptosis and ceramide formation in PC12 cellsRaja Goswami, John Kilkus, Bobbie Scurlock, et al.
Journal of Neuroscience Research|March 20, 2003
Ceramide in rafts (detergent-insoluble fraction) mediates cell death in neurotumor cell linesJohn Kilkus, Rajendra Goswami, Fernando D Testai, et al.
Cancers|April 17, 2019
Connecting Exosomes and ConnexinsJoanna Gemel, John Kilkus, Glyn Dawson, et al.
Journal of Neurochemistry|June 24, 2009
Oxidized phosphatidylcholine formation and action in oligodendrocytesJingdong Qin, Fernando D Testai, Sylvia Dawson, et al.
Glia|August 26, 2009
Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient miceLaleh Saadat, Jeffrey L Dupree, John Kilkus, et al.
Journal of Neuroscience Research|January 20, 2015
Changes in the metabolism of sphingolipids after subarachnoid hemorrhageFernando D Testai, Hao-Liang Xu, John Kilkus, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta|November 10, 2015
The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activityJingdong Qin, John Kilkus, Glyn Dawson
Neurochemical Research|October 11, 2002
CrmA protects against apoptosis and ceramide formation in PC12 cellsRaja Goswami, John Kilkus, Bobbie Scurlock, et al.
Journal of Neuroscience Research|March 20, 2003
Ceramide in rafts (detergent-insoluble fraction) mediates cell death in neurotumor cell linesJohn Kilkus, Rajendra Goswami, Fernando D Testai, et al.
Cancers|April 17, 2019
Connecting Exosomes and ConnexinsJoanna Gemel, John Kilkus, Glyn Dawson, et al.
Journal of Neurochemistry|June 24, 2009
Oxidized phosphatidylcholine formation and action in oligodendrocytesJingdong Qin, Fernando D Testai, Sylvia Dawson, et al.
Glia|August 26, 2009
Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient miceLaleh Saadat, Jeffrey L Dupree, John Kilkus, et al.
Journal of Neuroscience Research|January 20, 2015
Changes in the metabolism of sphingolipids after subarachnoid hemorrhageFernando D Testai, Hao-Liang Xu, John Kilkus, et al.
Pageof 1